                         SEQUENCE LISTING

<110>  Icahn School of Medicine at Mount Sinai
       Universitat fur Bodenkultur Wien
 
<120>  INFLUENZA VIRUS VACCINES AND USES THEREOF

<130>  6923-239-228

<140>  TBA
<141>  On Even date herewith

<150>  62/180,405
<151>  2015-06-16

<160>  30    

<170>  PatentIn version 3.5

<210>  1
<211>  25
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide 66-69

<400>  1

Ala Lys Leu Arg Met Val Thr Gly Leu Arg Asn Ile Pro Ser Ile Gln 
1               5                   10                  15      


Ser Arg Gly Leu Phe Gly Ala Ile Ala 
            20                  25  


<210>  2
<211>  25
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide 86-89

<400>  2

Lys Val Asp Asp Gly Phe Leu Asp Ile Trp Thr Tyr Asn Ala Glu Leu 
1               5                   10                  15      


Leu Val Leu Leu Glu Asn Glu Arg Thr 
            20                  25  


<210>  3
<211>  25
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide 106-109

<400>  3

Val Tyr Gln Ile Leu Ala Ile Tyr Ser Thr Val Ala Ser Ser Leu Val 
1               5                   10                  15      


Leu Leu Val Ser Leu Gly Ala Ile Ser 
            20                  25  


<210>  4
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide 69

<400>  4

Gln Ser Arg Gly Leu Phe Gly Ala Ile Ala 
1               5                   10  


<210>  5
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide 73

<400>  5

Val Asp Gly Trp Tyr Gly Tyr His His Gln 
1               5                   10  


<210>  6
<211>  25
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide 66-69 Derivative 

<400>  6

Val Thr Gly Leu Arg Asn Ile Pro Ser Ile Gln Ser Arg Gly Leu Phe 
1               5                   10                  15      


Gly Ala Ile Ala Gly Phe Ile Glu Gly 
            20                  25  


<210>  7
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide 96

<400>  7

Ile Gly Asn Gly Cys Phe Glu Phe Tyr His 
1               5                   10  


<210>  8
<211>  25
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide 69+73

<400>  8

Gln Ser Arg Gly Leu Phe Gly Ala Ile Ala Gly Gly Gly Gly Gly Val 
1               5                   10                  15      


Asp Gly Trp Tyr Gly Tyr His His Gln 
            20                  25  


<210>  9
<211>  25
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide 73+96

<400>  9

Val Asp Gly Trp Tyr Gly Tyr His His Gln Gly Gly Gly Gly Gly Ile 
1               5                   10                  15      


Gly Asn Gly Cys Phe Glu Phe Tyr His 
            20                  25  


<210>  10
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  G5 linker 

<400>  10

Gly Gly Gly Gly Gly 
1               5   


<210>  11
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  G5S Linker 

<400>  11

Gly Gly Gly Gly Gly Ser 
1               5       


<210>  12
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Streptavidin binding peptide 

<400>  12

Trp Ser His Pro Gln Phe Glu Lys 
1               5               


<210>  13
<211>  26
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide 73+96

<400>  13

Ser Val Asp Gly Trp Tyr Gly Tyr His His Gln Gly Gly Gly Gly Gly 
1               5                   10                  15      


Ile Gly Asn Gly Cys Phe Glu Phe Tyr His 
            20                  25      


<210>  14
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide 107

<400>  14

Ala Ile Tyr Ser Thr Val Ala Ser Ser Leu 
1               5                   10  


<210>  15
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Thrombin cleavage site 

<400>  15

Leu Val Pro Arg Gly Ser Pro 
1               5           


<210>  16
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  His Tag 

<400>  16

His His His His His His 
1               5       


<210>  17
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide 106

<400>  17

Val Tyr Gln Ile Leu Ala Ile Tyr Ser Thr 
1               5                   10  


<210>  18
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide 9

<400>  18

Val Thr Val Thr His Ser Val Asn Leu Leu 
1               5                   10  


<210>  19
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide 55

<400>  19

Phe Ala Leu Ser Arg Gly Phe Gly Ser Gly 
1               5                   10  


<210>  20
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide 66

<400>  20

Ala Lys Leu Arg Met Val Thr Gly Leu Arg 
1               5                   10  


<210>  21
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide 67

<400>  21

Val Thr Gly Leu Arg Asn Ile Pro Ser Ile 
1               5                   10  


<210>  22
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide 68

<400>  22

Asn Ile Pro Ser Ile Gln Ser Arg Gly Leu 
1               5                   10  


<210>  23
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide 87

<400>  23

Phe Leu Asp Ile Trp Thr Tyr Asn Ala Glu 
1               5                   10  


<210>  24
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide 88

<400>  24

Thr Tyr Asn Ala Glu Leu Leu Val Leu Leu 
1               5                   10  


<210>  25
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide 89

<400>  25

Leu Leu Val Leu Leu Glu Asn Glu Arg Thr 
1               5                   10  


<210>  26
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide 108

<400>  26

Val Ala Ser Ser Leu Val Leu Leu Val Ser 
1               5                   10  


<210>  27
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide 109

<400>  27

Val Leu Leu Val Ser Leu Gly Ala Ile Ser 
1               5                   10  


<210>  28
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide 25

<400>  28

Gln Leu Ser Ser Val Ser Ser Phe Glu Arg 
1               5                   10  


<210>  29
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide 100

<400>  29

Lys Asn Gly Thr Tyr Asp Tyr Pro Lys Tyr 
1               5                   10  


<210>  30
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide 86

<400>  30

Lys Val Asp Asp Gly Phe Leu Asp Ile Trp 
1               5                   10  


